Impact of the Administration of Fludrocortisone in Very Premature Infants
NCT03001089
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
66
Enrollment
OTHER
Sponsor class
Conditions
Partial Mineralocorticoid Deficiency
Interventions
DRUG:
Oral Fludrocortisone (enteral)
DRUG:
Placebo Oral Tablet
Sponsor
Assistance Publique - Hôpitaux de Paris